AI Human Genetics Platform Mystra Debuts for Drug Discovery, Validation
Officially unveiled at the American Society of Human Genetics (ASHG) 2025 meeting held in Boston, Genomics has launched…
LassoESM accelerates discovery of therapeutic peptides
In the hunt for new therapeutics for cancer and infectious diseases, lasso peptides prove to be a catch.…
SMOC1 gene plays a surprising role in the development of type 2 diabetes
Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in…
COMBINEDBrain and MUSC join forces to launch pediatric CNS biorepository
COMBINEDBrain, a leader in advancing translational neuroscience research, and the Medical University of South Carolina (MUSC), one of…
CellNavi predicts genes directing cellular transitions by learning a gene graph-enhanced cell state manifold
Input embeddings In CellNavi, we use single-cell raw count matrices as the only input. Specifically, the single-cell sequencing…
Preventing radiation damage with melanin-based material
Radiotherapy for abdominal and pelvic cancers almost always leads to small-intestine injuries that are difficult to heal,…
PROTACs and MGDs role in drug discovery
Stick, tag, destroy: The science of PROTACs and MGDs Traditional drug research has focused on creating inhibitors that…
DeepMind CEO Demis Hassabis: ‘AI could cut drug discovery from years to…’; how it is changing medicine worldwide |
Artificial intelligence (AI) is rapidly transforming industries, and the pharmaceutical sector is poised to be one of its…
Merck & Co. reveals monthly HIV-PrEP pill candidate
Scientists at Merck & Co. have unveiled the structure of the company’s latest candidate for HIV pre-exposure…
AI Model Finds Gene Targets and Drug Combos to Reprogram Diseased Cells
Credit: FlashMovie/Getty Images Traditional drug discovery has often followed the “one drug, one target” paradigm—developing compounds against individual…
Morphological map of under- and overexpression of genes in human cells
Mattiazzi Usaj, M. et al. High-content screening for quantitative cell biology. Trends Cell Biol. 26, 598–611 (2016). CAS …
Preclinical Data Spotlights Gene with Therapeutic Potential for Barth Syndrome
Barth Syndrome is a rare X-linked genetic condition caused by a mutation in the Tafazzin gene, which is…